EuroQol is committed to improve decisions about health and health care throughout the world by making available EQ-5D for research on the impact of COVID-19.
The EQ Office Team is handling all requests for using EQ-5D in COVID-19 research with priority. In line with our User Policy we do not charge a license fee for any non-commercial use of EQ-5D, large or small.
As a measure to accelerate research, we will not charge a license fee when commercial customers seek to use EQ-5D in clinical trials aimed at testing COVID-19 diagnostic tools or COVID-19 treatments. During this time, customers will receive a free of charge study-specific license. If you have an urgent request, please register on our website and send an email with the request tracking number to email@example.com to expedite the process.
Commercial customers with an existing EQ-5D license agreement can contact the EQ Office to obtain telephone- or face to face interviewer versions of EQ-5D temporarily free of charge to ensure that their clinical trials can continue during COVID-19.
Lastly, in order to process COVID-19 requests with priority we urge all customers to select existing EQ-5D versions and languages as much as possible, as creating translations and adaptations takes time. Moreover, please note that screenshot review is not needed when EQ-5D data is collected via REDCap, LimeSurvey or Castor EDC, which saves valuable time.